4/A//SEC Filing
Fattori Ruth A 4/A
Accession 0001104659-22-002888
CIK 0001833769other
Filed
Jan 9, 7:00 PM ET
Accepted
Jan 10, 9:40 PM ET
Size
7.9 KB
Accession
0001104659-22-002888
Insider Transaction Report
Form 4/AAmended
Hyperfine, Inc.HYPR
Fattori Ruth A
Director
Transactions
- Award
Class A Common Stock
2021-12-22+891→ 891 total - Award
Class A Common Stock
2021-12-23+19,586→ 20,477 total
Footnotes (3)
- [F1]In connection with the closing of the transactions contemplated by the Business Combination Agreement, dated as of July 7, 2021, by and among HealthCor Catalio Acquisition Corp. ("HealthCor"), Optimus Merger Sub I, Inc., a Delaware corporation and wholly owned subsidiary of HealthCor ("Merger Sub I"), Optimus Merger Sub II, Inc., a Delaware corporation and wholly owned subsidiary of HealthCor ("Merger Sub II"), Hyperfine, Inc., a Delaware corporation ("Hyperfine"), and Liminal Sciences, Inc., a Delaware corporation ("Liminal"), pursuant to which
- [F2]Merger Sub I merged with and into Hyperfine (the "Hyperfine Merger"), with Hyperfine surviving the Hyperfine Merger as a wholly owned subsidiary of HealthCor, and Merger Sub II merged with and into Liminal (the "Liminal Merger" and, together with the Hyperfine Merger, the "Mergers"), with Liminal surviving the Liminal Merger as a wholly owned subsidiary of HealthCor (which changed its name to "Hyperfine, Inc.", the "Issuer"), these shares were received in exchange for 4,962 shares of Liminal Series A-2 preferred stock.
- [F3]Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in equal annual installments over three years beginning on December 23, 2022, subject to Ms. Fattori's continued service through the applicable vesting date.
Documents
Issuer
Hyperfine, Inc.
CIK 0001833769
Entity typeother
Related Parties
1- filerCIK 0001306826
Filing Metadata
- Form type
- 4/A
- Filed
- Jan 9, 7:00 PM ET
- Accepted
- Jan 10, 9:40 PM ET
- Size
- 7.9 KB